Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 12.29
0.00 (0.00%)
At close: Apr 23, 2025, 2:57 PM CST
SHE:301301 Revenue
In the year 2024, Yili Chuanning Biotechnology had annual revenue of 5.76B CNY with 19.38% growth. Yili Chuanning Biotechnology had revenue of 1.30B in the quarter ending December 31, 2024, with 4.83% growth.
Revenue
5.76B
Revenue Growth
+19.38%
P/S Ratio
4.75
Revenue / Employee
1.81M
Employees
2,881
Market Cap
27.37B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |